1. Clinical remission at 52 weeks was similar between ustekinumab and adalimumab. 2. Patient-reported outcomes of stool frequency and abdominal…
Browsing: Hot headlines in GI
GE Healthcare is rolling out a set of wireless, portable sensors designed to be worn by patients during their hospital…
A randomized clinical trial indicated that add-on baclofen may be of benefit to patients on adequate doses of proton pump…
Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced that John Allen, MD,…
At a fork in the road, Aditya Khosla, Ph.D., is taking the path less traveled: one that will take him…